4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-016827
CHIEF ACCOUNTING OFFICER sold 9,316 shares at $19.13 ($178,215)
- CHIEF ACCOUNTING OFFICER acquired 9,316 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-12-19 | Option exercise 10b5-1 | +9,316 | $13.88 | $129,306 | 26,321 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-12-19 | Sale 10b5-1 | −9,316 | $19.13 | $178,215 | 17,005 | D |
| Derivatives | |||||||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2023-12-19 | Option exercise · Share Option 10b5-1 | −9,316 | 20,684 | D | ||
| Open-market sales · 9,316 sh · avg $19.13 · $178,215 | |||||||
Loading xslF345X05/form4-12212023_091222.xml…